The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Run-off Property-Liability; Protection Services; Allstate Health and Benefits; and Corporate and Other. The company offers private passenger auto, homeowners, personal lines, and commercial insurance products through agents, contact centers, and online; and property and casualty insurance products. It also provides consumer product protection plans, device and mobile data collection services, and analytic solutions using automotive telematics information, roadside assistance, and protection plans; and insurance products, such as identity protection and restoration through Allstate Protection Plans, Allstate Dealer Services, Allstate Roadside, Arity, and Allstate Identity Protection brands. In addition, the company offers life, accident, critical illness, hospital indemnity, short-term disability, and other health insurance products; self-funded stop-loss and fully insured group health products to employers; medicare supplement, ancillary products, and short-term medical insurance to individuals through independent agents, owned agencies, benefits brokers, and Allstate exclusive agents. Further, it offers automotive protection; vehicle service contracts, guaranteed asset protection, road hazard tires and wheels, and paintless dent repair protection; and roadside assistance, mobility data collection services, and analytic solutions using automotive telematics information, identity theft protection, and remediation services. The Allstate Corporation was founded in 1931 and is headquartered in Northbrook, Illinois.

Allstate Corporation (The)

Analysts have been eager to weigh in on the Technology sector with new ratings on Allot (ALLT – Research Report) and Intel (INTC – Research Report)...

Analysts Offer Insights on Technology Companies: Allot (ALLT) and Intel (INTC)

In a report released today, Elyse Greenspan from Wells Fargo maintained a Hold rating on Allstate, with a price target of $216.00. According to Tip...

Allstate (ALL) Receives a Hold from Wells Fargo

KBW analyst Meyer Shields maintained a Buy rating on Allstate yesterday and set a price target of $250.00. The company’s shares closed yesterday at...

KBW Reaffirms Their Buy Rating on Allstate (ALL)

Allot Communications ( ($ALLT) ) has released its Q3 earnings. Here is a breakdown of the information Allot Communications presented to its investo...

Allot Ltd. Reports Strong Q3 2025 Financial Growth

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Allot (ALLT – Research Report) and Nvidia (NVDA – Re...

Analysts Offer Insights on Technology Companies: Allot (ALLT) and Nvidia (NVDA)

Citi analyst Andrew Lowe maintained a Buy rating on Allfunds Group plc today and set a price target of €9.10. Lowe covers the Financial sector, foc...

Allfunds Group plc (6UY) Receives a Buy from Citi

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on MetroCity Bankshares (MCBS – Research Report), Jeff...

Analysts Conflicted on These Financial Names: MetroCity Bankshares (MCBS), Jefferson Capital, Inc. (JCAP) and Ally Financial (ALLY)

Macquarie analyst maintained a Buy rating on Aristocrat Leisure today and set a price target of A$75.00. In addition to Macquarie, Aristocrat Leisu...

Macquarie Sticks to Its Buy Rating for Aristocrat Leisure  (ARLUF)

Jefferies analyst maintained a Buy rating on Ball today and set a price target of $64.00. In addition to Jefferies, Ball also received a Buy from T...

Jefferies Keeps Their Buy Rating on Ball (BALL)

In a report released yesterday, Robert Burns from H.C. Wainwright reiterated a Buy rating on Allogene Therapeutics, with a price target of $8.00. T...

Allogene Therapeutics (ALLO) Receives a Buy from H.C. Wainwright

Allot ( ($ALLT) ) has provided an announcement. On November 4, 2025, Allot Ltd. announced it will hold its Annual General Meeting of Shareholders o...

Allot Ltd. Schedules Annual General Meeting for December 2025

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Allogene Therapeutics (ALLO – Research Report), Neur...

Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO), NeurAxis, Inc. (NRXS) and Celcuity (CELC)

Citi analyst Adrian Lemme maintained a Buy rating on Aristocrat Leisure today and set a price target of A$71.00. According to TipRanks, Lemme is a ...

Citi Keeps Their Buy Rating on Aristocrat Leisure  (ARLUF)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Allogene Therapeutics (ALLO – Research Report), Ha...

Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO), Halozyme (HALO) and Progyny (PGNY)

Oppenheimer analyst Matthew Biegler reiterated a Buy rating on Allogene Therapeutics yesterday and set a price target of $7.00. Biegler covers the ...

Allogene Therapeutics (ALLO) Gets a Buy from Oppenheimer

Cantor Fitzgerald analyst Ryan Tunis maintained a Hold rating on Allstate yesterday and set a price target of $202.00. Tunis covers the Financial s...

Allstate (ALL) Receives a Hold from Cantor Fitzgerald

Analysts have been eager to weigh in on the Financial sector with new ratings on Ally Financial (ALLY – Research Report) and OneMain Holdings (OMF ...

Analysts Offer Insights on Financial Companies: Ally Financial (ALLY) and OneMain Holdings (OMF)

Morgan Stanley analyst Melinda Baxter maintained a Buy rating on Aristocrat Leisure today and set a price target of A$73.70. The company’s shares c...

Morgan Stanley Keeps Their Buy Rating on Aristocrat Leisure  (ARLUF)

Barclays analyst Julian Mitchell maintained a Hold rating on Allegion today and set a price target of $187.00. The company’s shares closed yesterda...

Barclays Reaffirms Their Hold Rating on Allegion (ALLE)

Mizuho Securities analyst Brett Linzey maintained a Hold rating on Allegion yesterday and set a price target of $170.00. The company’s shares close...

Market Cap	$50.91B	P/E Ratio	7.75
52W High	$215.70	52W Low	$176.00
Div Yield	400.0%	Payout Ratio	89.6%
EPS Growth 3Y	N/A	52W Position	98.2%
Overall Score	95	Value Score	100
Quality Score	--	Technical Score	91

EPS Current Est	$27.73	EPS Next Est	$23.75
EPS Growth Est	-14.4%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ALL	$214.99	+1.53%	843.92K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ALL	$214.99	+1.5%	843.92K
3
4
5
6

ALL

ALL

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Allstate Corporation (The) Data in Excel

Get Allstate Corporation (The) Data in Excel